Here's a slide deck with data about the results of the trial (of Glucose Insulin Potassium) mentioned in the article.

http://clinicaltrialresults.org/Slides/ACC2012/Selker_IMMEDI...

From the conclusions slide:

"Composite endpoint of cardiac arrest or acute mortality was significantly reduced, and FFA levels were lower, consistent with the proposed FFA link to arrhythmias"